Arkolith/Insider Trading/FHTX/Form 4

Costa Carlos

Chief People OfficerFoghorn Therapeutics Inc. (FHTX) · full profile →Form 4 · filed Sep 24, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$368K
Net Open-Market Flow
-$368K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 23, 2024Option exercise(M)857$3.72$3K857
Sep 23, 2024Sell(S)857$10.17$9K0
Sep 20, 2024Sell(S)36K$10.04$359K0
Sep 20, 2024Option exercise(M)36K$3.72$133K36K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 23, 2024Option exercise(M)857—$040K
Sep 20, 2024Option exercise(M)36K—$041K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-24-006927) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML